ArticleJournal of clinical laboratory analysis2019

Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio can predict clinical outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab.

Jingjing Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.